Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02495402 · ClinicalTrials.gov registry record · NA
Substance Abuse Treatment to HIV Care (SAT2HIV): The Motivational Interviewing-based Brief Intervention Experiment
A NA study of Substance Use, sponsored by RTI International.
- Completed
- Registry status
- NA
- Development phase
- 827
- Enrollment target
- 20
- Study locations
NCT02495402: Completed NA study of Substance Use, sponsored by RTI International.
NCT02495402 is a NA study of Substance Use that has completed, run by RTI International. The registered enrollment target is 827 participants, below the 1,251-participant average among 88 other Substance Use trials with a reported enrollment target (34% lower). The trial reports 20 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02495402, a NA study of Substance Use, has completed, sponsored by RTI International.
- COMPLETED
- Registry status
- NA
- Development phase
- 827 participants
- Enrollment target
- 20
- Study locations
Study Summary
To test the effectiveness of a single 20-30 minute motivational interviewing-based brief intervention for substance use within HIV/AIDS settings.
Primary Outcome
Days of Primary Substance Use - A continuous measure (ranges from 0 - 28) that is based on a question that asks participants to report how many days during the past 28 days they used their primary substance.
Conditions Studied
Interventions
- BEHAVIORAL Motivational Interviewing
Study Locations (20)
California
- Foothill AIDS Project - Claremont
- AIDS Services Foundation, Orange County - Irvine
- AIDS Project Los Angeles - Los Angeles
- Shanti - San Francisco
Michigan
- Health Emergency Lifeline Programs (Collaborating Organization) - Detroit
- Community Health Awareness Group (Collaborating Organization) - Detroit
- Community AIDS Resources and Education Services (Collaborating Organization) - Kalamazoo
Connecticut
- AIDS Project Greater Danbury, Inc. - Danbury
- AIDS Connecticut, Inc - Hartford
Arizona
- HIV Care Directions - Phoenix
Delaware
- Delaware HIV Consortium - Wilmington
District of Columbia
- The Women's Collective - Washington D.C.
Florida
- Project Response, Inc. - Melbourne
Georgia
- Live Forward (AIDS Athens) - Athens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 827 participants |
| Start Date | 2015-07-08 |
| Est. Completion | 2018-03-25 |
| Phase | NA |
What the finished NCT02495402 record still lists
NCT02495402 is an interventional study that assigns participants to a tested intervention. The registered 827 participants enrollment target is mid-sized for trials with a published cap, below the 1,251-participant average among 88 other Substance Use trials with a reported enrollment target (34% lower).
The record links to 1 condition, with Substance Use appearing as the primary indexed condition, and to 1 intervention - of which Motivational Interviewing is the first listed.
NCT02495402 names 20 study sites across 14 states, led by California, Michigan, Connecticut.
Frequently Asked Questions
What is clinical trial NCT02495402 about?
NCT02495402 is a clinical study titled "Substance Abuse Treatment to HIV Care (SAT2HIV): The Motivational Interviewing-based Brief Intervention Experiment". To test the effectiveness of a single 20-30 minute motivational interviewing-based brief intervention for substance use within HIV/AIDS settings.
What is the current status of trial NCT02495402?
This trial is currently completed. It is a NA study. The enrollment target is 827 participants. The study started on 2015-07-08. Estimated completion is 2018-03-25.
What conditions does trial NCT02495402 study?
This clinical trial studies the following conditions: Substance Use.
What interventions are being tested in trial NCT02495402?
The interventions under investigation include: Motivational Interviewing (BEHAVIORAL).
Who is sponsoring clinical trial NCT02495402?
This trial is sponsored by RTI International, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02495402 being conducted?
This trial has 20 study locations across Arizona, California, Connecticut, Delaware, District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02495402's enrollment target sits among peer trials
827 9th of 88 higher than 80 of 88 other Substance Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Native Spirit: Significant Aim 3: Intervention
RECRUITING · NA
-
Parent SMART (Substance Misuse in Adolescents in Residential Treatment)
RECRUITING · NA
-
Cultural Adaptation of Drug Treatment for DJJ Youth
RECRUITING · NA
-
Adaptation and Evaluation of Bright Horizons
RECRUITING · NA
-
Teen Health Choices & Wellness
RECRUITING · NA
-
Pre-exposure Prophylaxis (PrEP) Uptake and Adherence Intervention for Women with Trauma-related Conditions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03547973 · 827 participants · Phase 2
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread
- NCT05124808 · 828 participants · NA
Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
- NCT05630482 · 825 participants · NA
Randomized Trial of Healthy Family Foundations
- NCT06097728 · 825 participants · Phase 3
MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI